William Blair research analyst Matt Phipps was quoted in this CNBC outlook story covering how healthcare stocks will perform in 2023.
“Several companies that had provided strong clinical data were able to raise funds [in 2022],” Phipps said.
Equity Research
William Blair research analyst Matt Phipps was quoted in this CNBC outlook story covering how healthcare stocks will perform in 2023.
“Several companies that had provided strong clinical data were able to raise funds [in 2022],” Phipps said.
Stay up-to-date with the latest William Blair news and insights
One topic we have increasingly been receiving questions on over the last few weeks has been private credit, and in this Economics Weekly, we address concerns about whether recent emerging issues in the space pose a systemic threat to the banking system and the wider economy.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures